Pharmacokinetics–Pharmacodynamics Modeling for Evaluating Drug–Drug Interactions in Polypharmacy: Development and Challenges
D Zhao, P Huang, L Yu, Y He - Clinical Pharmacokinetics, 2024 - Springer
Polypharmacy is commonly employed in clinical settings. The potential risks of drug–drug
interactions (DDIs) can compromise efficacy and pose serious health hazards. Integrating …
interactions (DDIs) can compromise efficacy and pose serious health hazards. Integrating …